Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Praxis Precision Medicines, Inc.(PRAX) | 19,882 | 32,810 | +12,928 | $5.86M | $10.57M | 10.50% | +$4.71M |
| Minerva Neurosciences, Inc.(NERV) | 1,655,500 | 1,655,500 | 0 | $6.66M | $9.97M | 9.91% | +$3.32M |
| Soleno Therapeutics Inc | 168,029 | 200,000 | +31,971 | $7.78M | $6.70M | 6.65% | -$1.08M |
| Ovid Therapeutics Inc.(OVID) | 1,785,000 | 2,818,459 | +1,033,459 | $2.91M | $6.26M | 6.22% | +$3.35M |
| COMPASS Pathways plcADS(CMPS) | 0 | 1,045,000 | +1,045,000 | $0 | $5.78M | 5.74% | +$5.78M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 0 | 80,859 | +80,859 | $0 | $5.67M | 5.64% | +$5.67M |
| Solid Biosciences Inc | 413,625 | 766,974 | +353,349 | $2.33M | $5.52M | 5.49% | +$3.19M |
| ProMIS Neurosciences, Inc.(PMN) | 249,339 | 414,219 | +164,880 | $1.70M | $5.26M | 5.23% | +$3.56M |
| Edgewise Therapeutics, Inc.(EWTX) | 195,000 | 161,000 | -34,000 | $4.84M | $5.07M | 5.04% | +$232.6K |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 397,895 | 660,375 | +262,480 | $3.00M | $4.78M | 4.75% | +$1.78M |
| CytomX Therapeutics, Inc.(CTMX) | 0 | 900,000 | +900,000 | $0 | $4.23M | 4.20% | +$4.23M |
| Inventiva S.A.ADS(IVA) | 1,500,000 | 745,300 | -754,700 | $6.97M | $4.14M | 4.11% | -$2.84M |
| Perspective Therapeutics, Inc.(CATX) | 0 | 926,557 | +926,557 | $0 | $3.86M | 3.84% | +$3.86M |
| ABIVAX Société AnonymeADS(ABVX) | 70,000 | 33,712 | -36,288 | $9.44M | $3.75M | 3.73% | -$5.69M |
| Alumis Inc | 0 | 166,959 | +166,959 | $0 | $3.68M | 3.65% | +$3.68M |
| UroGen Pharma Ltd.(URGN) | 0 | 202,124 | +202,124 | $0 | $3.63M | 3.61% | +$3.63M |
| Capricor Therapeutics, Inc.(CAPR) | 0 | 113,899 | +113,899 | $0 | $3.46M | 3.44% | +$3.46M |
| Whitehawk Therapeutics, Inc.(WHWK) | 817,939 | 817,939 | 0 | $1.98M | $2.82M | 2.80% | +$842.5K |
| Inhibikase Therapeutics, Inc.(IKT) | 0 | 1,325,000 | +1,325,000 | $0 | $2.23M | 2.21% | +$2.23M |
| An2 Therapeutics Inc | 0 | 526,315 | +526,315 | $0 | $1.80M | 1.79% | +$1.80M |
| Relmada Therapeutics, Inc.(RLMD) | 0 | 210,525 | +210,525 | $0 | $1.47M | 1.46% | +$1.47M |
| Atai Beckley NvSHS | 1,713,105 | 0 | -1,713,105 | $7.01M | $0 | — | -$7.01M |
| Taysha Gene Therapies, Inc.(TSHA) | 457,132 | 0 | -457,132 | $2.51M | $0 | — | -$2.51M |